The IHU ICAN (Foundation for Innovation in Cardiometabolism and Nutrition) explains what cardiometabolic diseases are.
- “Diabetes, obesity, fatty liver disease and hypercholesterolemia are chronic conditions. Associated with heart pathologies, they are called cardiometabolic diseases,” indicates the IHU ICAN.
- “Cardiometabolic diseases represent a major public health issue, because millions of people are affected across the French population,” adds the research center.
- Faced with the general public’s lack of knowledge about these pathologies revealed during the IFOP/IHU ICAN survey in November 2023, the center has set up a “National Cardiometabolic Diseases Week”.
What are cardiometabolic diseases? At the initiative of an awareness week, the fFoundation for Innovation in Cardiometabolism and Nutrition (IHU ICAN) gives us precise answers.
Cardiometabolic diseases: millions of people affected
“Diabetes, obesity, fatty liver disease and hypercholesterolemia are chronic conditions. Associated with heart pathologies, they are called cardiometabolic diseases”, indicates the research center in a press release.
“Cardiometabolic diseases represent a major public health challenge, because millions of people are affected across the French population,” can also be read in the document sent to the editorial staff.
In fact, 140,000 patients die each year from cardiovascular disease in our territory, 31.9 million French people are overweight, 17 million people suffer from high blood pressure and 4 million people are treated for diabetes.
Faced with these alarming figures and the general public’s lack of knowledge about these pathologies revealed during the IFOP/IHU ICAN survey of November 2023, the center has set up a “National Cardiometabolic Disease Week”.
“Cardiometabolic diseases disrupt quality of life”
“These chronic conditions disrupt the quality of life of many people and lead to very serious or even fatal pathologies. Our objective is to raise awareness to lead to lasting changes in behavior and earlier detection of cardiometabolic diseases , in order to set up anticipated and personalized support”, comments Professor Stéphane Hatem, Director General of IHU ICAN.
“To fight against cardiometabolic diseases, we can all act. Lifestyle, diet, physical activity, alcohol consumption and smoking are in fact risk factors which play a major role in the However, other factors must also be taken into account such as genetic predispositions. specifies the press release.
“Faced with the public health challenge represented by cardiometabolic diseases, only multidisciplinary and innovative research will provide an effective response. This is why it is also important to give researchers the means to carry out ambitious and innovative research programs” , concludes the IHU ICAN.
